Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Rapid weight loss from semaglutide use can lead to breast ptosis, mirroring effects seen after bariatric surgery. Healthcare providers should be prepared to counsel patients on this potential outcome and offer strategies for management.
Endocrinology, Diabetes, Metabolism July 17th 2024
GoodRx for Healthcare Professionals
Several medications, including antihistamines, muscle relaxers, and benzodiazepines, are known to cause fatigue. Understanding these effects and managing patient expectations can help mitigate this common side effect.
All Specialties June 4th 2024
Oncology News Central (ONC)
MacroGenics’ Phase II TAMARACK trial for vobramitamab duocarmazine in metastatic prostate cancer reported five patient deaths, raising critical safety concerns but also highlighting promising response rates that could influence future treatment protocols.
Oncology, Medical June 4th 2024
Interim results from J&J’s Phase I study of JNJ-6420 highlight both promising efficacy in prostate cancer treatment and serious safety concerns, with 60% of patients experiencing severe adverse events.
Oncology, Medical June 3rd 2024
Healthline
Patients on GLP-1 medications may experience notable changes in breast morphology, such as decreased volume and increased sagging. Medical experts recommend supportive measures and a stable weight before considering surgical interventions.
Obstetrics & Gynecology May 17th 2024
Recent studies highlight that while meditation is beneficial for many, it can also lead to significant mental health challenges, including anxiety, psychosis, and depersonalization, particularly in intense meditative practices.
Psychiatry May 14th 2024